Lorraine Christie Porter
Directeur/Membre du Conseil chez TCB Newco Ltd.
Profil
Lorraine Christie Porter was the founder of STATS Group Ltd., which was founded in 1998, where she held the title of Co-Managing Director.
Currently, she holds the position of Non-Executive Director at TCB Newco Ltd.
Postes actifs de Lorraine Christie Porter
Sociétés | Poste | Début |
---|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lorraine Christie Porter
Sociétés | Poste | Fin |
---|---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Industrial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |